CATALOGO DEI PRODOTTI DELLA RICERCA

PERBELLINI, Omar
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.586
EU - Europa 6.078
AS - Asia 3.930
SA - Sud America 446
Continente sconosciuto - Info sul continente non disponibili 99
AF - Africa 81
OC - Oceania 19
Totale 18.239
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.329
RU - Federazione Russa 2.024
GB - Regno Unito 1.402
SG - Singapore 1.393
CN - Cina 1.368
DE - Germania 596
IT - Italia 518
SE - Svezia 402
BR - Brasile 341
VN - Vietnam 321
FI - Finlandia 293
HK - Hong Kong 289
FR - Francia 279
IE - Irlanda 245
CA - Canada 141
KR - Corea 115
BD - Bangladesh 105
IN - India 78
UA - Ucraina 63
NL - Olanda 55
JP - Giappone 47
TR - Turchia 47
BE - Belgio 40
MX - Messico 39
PL - Polonia 32
AR - Argentina 31
ES - Italia 28
ID - Indonesia 26
ZA - Sudafrica 24
NG - Nigeria 19
EC - Ecuador 17
AU - Australia 16
UZ - Uzbekistan 16
CO - Colombia 15
CR - Costa Rica 15
PK - Pakistan 15
CL - Cile 14
IQ - Iraq 14
IR - Iran 14
AT - Austria 13
RO - Romania 12
HN - Honduras 11
LT - Lituania 11
VE - Venezuela 11
NP - Nepal 10
SV - El Salvador 10
JM - Giamaica 9
DK - Danimarca 8
TW - Taiwan 8
PE - Perù 7
CZ - Repubblica Ceca 6
HU - Ungheria 6
IL - Israele 6
KE - Kenya 6
KZ - Kazakistan 6
MA - Marocco 6
NI - Nicaragua 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
GR - Grecia 5
LV - Lettonia 5
OM - Oman 5
PH - Filippine 5
PR - Porto Rico 5
PY - Paraguay 5
SI - Slovenia 5
TT - Trinidad e Tobago 5
AL - Albania 4
BG - Bulgaria 4
CW - ???statistics.table.value.countryCode.CW??? 4
EG - Egitto 4
HR - Croazia 4
JO - Giordania 4
MY - Malesia 4
PA - Panama 4
TH - Thailandia 4
AM - Armenia 3
BO - Bolivia 3
CY - Cipro 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EU - Europa 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
BJ - Benin 2
BS - Bahamas 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
LU - Lussemburgo 2
NO - Norvegia 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
RW - Ruanda 2
TG - Togo 2
Totale 18.120
Salva come PNG Salva come JPEG
Città #
Ashburn 1.284
Southend 1.149
Singapore 741
Moscow 713
San Jose 604
Chandler 584
Dallas 563
Jacksonville 457
Woodbridge 422
Ann Arbor 397
Beijing 299
Hong Kong 280
Dublin 245
Council Bluffs 205
Munich 202
New York 201
Verona 164
The Dalles 154
Houston 140
Wilmington 127
Los Angeles 120
Helsinki 101
Jinan 95
Ho Chi Minh City 92
Lawrence 87
Princeton 87
Hanoi 80
Nanjing 80
Shenyang 65
Tianjin 64
São Paulo 63
Santa Clara 58
Buffalo 55
Milan 47
Hebei 45
Orem 43
Turku 42
Tokyo 41
Falls Church 40
Columbus 39
Brussels 38
Montreal 38
Haikou 35
Hangzhou 35
Toronto 35
Boardman 33
Manchester 33
Ningbo 33
Nanchang 31
Zhengzhou 31
Changsha 30
Guangzhou 30
Chennai 28
Seoul 28
Frankfurt am Main 27
Stockholm 27
London 26
Chicago 25
Norwalk 25
Warsaw 24
Denver 23
Rome 23
Boston 22
Groningen 22
Johannesburg 22
Taiyuan 22
Redondo Beach 21
Brooklyn 20
Seattle 20
Sindelfingen 20
Taizhou 20
Amsterdam 18
Atlanta 18
Dearborn 17
Jiaxing 17
Bologna 16
Düsseldorf 16
Nürnberg 16
Phoenix 16
San Francisco 16
Abuja 15
Fuzhou 15
Haiphong 14
Paris 14
Tashkent 14
Washington 14
Charlotte 13
Dong Ket 13
Jakarta 13
Lanzhou 13
Naples 13
Falkenstein 12
Redmond 12
Da Nang 11
Kent 11
Mexico City 11
Redwood City 11
Mumbai 10
San José 10
Santiago 10
Totale 11.521
Salva come PNG Salva come JPEG
Nome #
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 465
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 354
DEATH RECEPTOR 3 EXPRESSION AND SERUM LEVEL OF SOLUBLE TL1A CORRELATE WITH INDOLENT, EARLY STAGE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 309
Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia 305
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 282
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 278
NON-CANONICAL NOTCH SIGNALING IN T-ALL: A PHOSPHO-FLOW CYTOMETRY STUDY 277
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 269
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 268
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 265
A quantitative study on the growth variability of tumour cell clones in vitro 261
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 260
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 259
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 252
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients. 251
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 250
BCR-signaling profiles associated with prognosis and progression in B-CLL 247
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 247
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 243
Characterization of the cross-talk between human neutrophils and a subset of pro-inflammatory dendritic cells 242
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 242
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 236
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 234
BCR-signaling profiles associated with prognosis and progression in B-CLL 230
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 228
A simple score predicts clonal mast cell disorders in patients with systemic reactions to Hymenoptera venom without skin lesions 228
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 227
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels 224
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 222
Cross-talks within the innate immune system: the role of neutrophils 221
Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and hymenopteria allergy 220
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 220
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 219
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 216
IN VITRO STUDY OF THE MECHANISMS INVOLVED IN THE BONE MARROW MESENCHY- MAL STROMAL CELL MODULATORY EFFECT ON B CELL FUNCTIONS 215
Jagged-1, Jagged-2 and DLL-1 are the elements of Notch signaling mainly responsible for the antiapoptotic effect on B-lineage acute lymphoblastic leukemia exerted by bone marrow Mesenchymal Stem Cells 214
METHODOLOGICAL APPROACH TO MINIMAL RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA 213
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 210
Effects of wheat germ agglutinin on human gastrointestinal epithelium: insights from an experimental model of immune/epithelial cell interaction 208
Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1 and ICAM-3 208
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 203
Human Bone marrow Mesenchymal Stem Cells protect B-cell Acute Lymphoblastic Leukemia from apoptosis in vitro by upregulation of Notch3 and Notch4 on both cell types 201
EXPRESSION AND FUNCTIONAL ACTIVITY OF THE TNFR-SUPERFAMILY MEMBER DEATH RECEPTOR 3 IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS ACTIVATED BY THE BCR 201
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 201
Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis. 200
Improved detection of the C-KIT D816V mutation using allele-specific arms real time PCR assay allows a finer recognition of patients with indolent systemic mastocytosis. 198
A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis 198
On the potential involvement of CD11d in co-stimulating the production of interferon-{gamma} by natural killer cells upon interaction with neutrophils via intercellular adhesion molecule-3 197
Flow cytometry analysis of B-cell receptor phospho-protein networks in chronic lymphocytic leukemia 196
Underdiagnosed systemic mastocytosis: The role of flow cytometry 195
SIGNALING NETWORK IN T-CELL LYMPHOBLASTIC LEUKEMIA: RESULTS FROM A SINGLE-CELL MULTI-PARAMETRIC PHOSPHO-FLOW CYTOMETRY STUDY 195
Low catalase expression confers redox hypersensitivity and identifies an indolent clinical behavior in CLL 191
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 190
IDENTIFICATION AND CHARACTERIZATION OF CANDIDATE MYELOID DERIVED SUP- PRESSOR CELLS IN THE MONONUCLEAR FRACTION OF PERIPHERAL BLOOD SAMPLES FROM PATIENTS AFFECTED BY NON-HODGKIN LYMPHOMA (NHL), HODGKIN LYMPHOMA (HL), AND MULTIPLE MYELOMA (MM) 188
Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells 186
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 186
THE TNF-FAMILY CYTOKINE TL1A/DEATH RECEPTOR 3 FUNCTIONAL AXIS MODULATES B- CELL CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION 183
In Vitro Study Of The Mechanisms Involved In The Bone Marrow Mesenchymal Stromal Cell Modulatory Effect On B Cell Function 179
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 175
Serum tryptase levels differently change over time in indolent systemic mastocytosis with or without skin lesions. 175
The combination of Serum Thymidine Kinase, Beta-2-Microglobulin and soluble CD23 at diagnosis is predictive for progression in B-cell Chronic Lymphocytic Leukemia, independently from ZAP-70 expression 173
Interleukin 7 requirement for survival of T-cell acute lymphoblastic leukemia and human thymocytes on bone marrow stroma. 173
Adult T-cell acute lymphoblastic leukemia: prognostic impact of myeloid associated antigens. 172
Notch-3 and Notch-4 signaling rescues from apoptosis Human B-lineage Acute Lymphoblastic Leukemia cells in contact with Human Bone marrow-derived Mesenchymal Stromal Cells 170
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks 170
The TNF-Family Cytokine TL1A/Death Receptor 3 System Reduces Metabolic Activity in Chronic Lymphocytic Leukemia B Cells 168
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis 166
Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival 166
Neutrophil activation and survival are modulated by interaction with NK cells 163
Up-regulation of CXCL8/interleukin-8 production in response to CXCL12 in chronic lymphocytic leukemia 162
High incidence of autoimmune complications in 82 patients with non-MALT marginal zone lymphomas. 161
EPSTEIN-BARR VIRUS DNA LOAD IN CHRONIC LYMPHOCYTIC LEUKEMIA IS AN INDEPENDENT PREDICTOR OF CLINICAL COURSE AND SURVIVAL 157
Bone marrow stromal cells up-regulate interleukin 8 production in human T-lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-κB and JNK/AP-1 pathways 156
Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells 156
Multi-parametric phospho-flow cytometry in T-call Acute Lymphoblastic Leukemia 156
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 154
Ultra-Deep Sequencing (UDS) Allows More Sensitive Detection of the D816V and Other Kit Gene Mutations in Systemic Mastocytosis 153
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases 152
Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases 138
Systemic Reactions After Hymenoptera Sting And Raised Serum Tryptase Strongly Suggest Clonal Mast Cells Disorders 133
Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome 133
Outcome prediction by immunophenotypic minimal residual disease detection in adult T-cell acute lymphoblastic leukaemia 132
Rituximab, bendamustine and cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma 131
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 124
Flow-cytometric detection of minimal residual disease in adult acute lymphoblastic leukemia 116
On the co-purification of 6-sulfo LacNAc(+) dendritic cells (slanDC) with NK cells enriched from human blood. 114
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells 111
Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders 106
Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia 80
null 70
null 55
Direct-Acting Antiviral Agents in Hepatitis C-Associated Indolent Lymphomas 11
Totale 18.239
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.943
article - articoli 27.976
book - libri 0
conference - conferenze 26.967
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.886
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022524 0 0 0 83 68 33 20 48 40 23 60 149
2022/20231.667 103 192 134 320 135 403 17 99 206 13 33 12
2023/2024938 51 72 55 76 102 209 60 66 7 47 126 67
2024/20252.148 95 149 85 342 64 95 146 100 359 127 208 378
2025/20266.762 441 385 488 1.151 1.691 455 575 314 550 428 134 150
2026/20271.525 164 207 352 802 0 0 0 0 0 0 0 0
Totale 18.239